NSE · Source: INVESTORGAIN
From the prospectus, ordered by severity. Wording is close to the filing — not softened.
Regulatory Challenges
The company is subject to extensive regulatory requirements in India and internationally, which could impact its ability to market products.
Regulatory · high
Dependency on Key Products
The company relies heavily on its Vascular Intervention devices, particularly the Supraflex Cruz, which contributes significantly to its revenue.
Operational · high
Financial Dependencies
The company has incurred losses in the past and has significant working capital requirements.
Financial · high
Supply Chain Disruptions
Fluctuations in raw material costs and foreign currency exchange rates pose further risks to financial performance.
Operational · medium
Competition and Market Position
The company faces intense competition in the medical devices industry and must continuously innovate to maintain its market position.
Market · medium